ClinConnect ClinConnect Logo
Search / Trial NCT00628459

Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area

Launched by CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE · Mar 4, 2008

Trial Information

Current as of July 04, 2025

Completed

Keywords

Iron Multiple Micronutrient Malaria Anemia Preschool Children

ClinConnect Summary

This is a community-based randomised double-blind trial. Children aged 6-23 months are randomised to receive either iron (n=91), iron and zinc (IZ, n=90) or MMN (n=89), 5 days/week for 6 months. Supplements are manufactured by Nutriset (Malaunay, France) as specifically fortified "plumpy-nut". They are presented in 90 ml boxes coded A, B and C each lot of boxes contained in white packing labelled A, B and C respectively. Malaria is managed in concordance with the national malaria program standards. All mothers receive one insecticide-treated bed-net (PermaNet®, Vestergaard Frandsen Disease ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age of 6-23 months
  • hemoglobin concentration range of 70-109 g/L
  • Exclusion Criteria:
  • severe wasting (weight-for-height z-score \< -3)

About Centre National De La Recherche Scientifique Et Technologique

The Centre National de la Recherche Scientifique et Technologique (CNRST) is a premier research institution dedicated to advancing scientific knowledge and innovation in various fields, including health and medicine. As a clinical trial sponsor, CNRST focuses on fostering collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. With a commitment to rigorous scientific methodologies and ethical standards, CNRST plays a pivotal role in driving impactful research that addresses critical health challenges and enhances public health initiatives.

Locations

Kongoussi, , Burkina Faso

Patients applied

0 patients applied

Trial Officials

Philippe Donnen, PhD

Study Director

Université Libre de Bruxelles, Belgium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials